Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC, 87458-87459 [2023-27708]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
87458
Federal Register / Vol. 88, No. 241 / Monday, December 18, 2023 / Notices
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due, notwithstanding § 201.14(a)
of the Commission’s Rules of Practice
and Procedure. No other submissions
will be accepted, unless requested by
the Commission. Any submissions and
replies filed in response to this Notice
are limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above. Submissions should refer
to the docket number (‘‘Docket No.
3712’’) in a prominent place on the
cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, Electronic Filing
Procedures 1). Please note the
Secretary’s Office will accept only
electronic filings during this time.
Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov.) No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary atEDIS3Help@usitc.gov.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
1 Handbook
for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
VerDate Sep<11>2014
17:41 Dec 15, 2023
Jkt 262001
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: December 13, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–27767 Filed 12–15–23; 8:45 am]
BILLING CODE 7020–02–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Advisory Committee on Bankruptcy
Rules; Hearing of the Judicial
Conference
Judicial Conference of the
United States.
ACTION: Advisory Committee on
Bankruptcy Rules; Notice of
cancellation of open hearing.
AGENCY:
The following public hearing
on proposed amendments to the Federal
Rules of Bankruptcy Procedure has been
canceled: Bankruptcy Rules Hearing on
January 12, 2024. The announcement for
this hearing was previously published
in the Federal Register on August 9,
2023.
DATES: January 12, 2024.
FOR FURTHER INFORMATION CONTACT: H.
Thomas Byron III, Esq., Chief Counsel,
Rules Committee Staff, Administrative
Office of the U.S. Courts, Thurgood
Marshall Federal Judiciary Building,
One Columbus Circle NE, Suite 7–300,
Washington, DC 20544, Phone (202)
502–1820, RulesCommittee_Secretary@
ao.uscourts.gov.
SUMMARY:
(Authority: 28 U.S.C. 2073.)
[FR Doc. 2023–27766 Filed 12–15–23; 8:45 am]
BILLING CODE 2210–55–P
2 All contract personnel will sign appropriate
nondisclosure agreements.
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
Frm 00074
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–1308]
Bulk Manufacturer of Controlled
Substances Application: Kinetochem
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Kinetochem LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 16, 2024. Such
persons may also file a written request
for a hearing on the application on or
before February 16, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 28, 2023,
Kinetochem LLC, 96 Market Street,
Suite 102, Georgetown, Texas 78626–
3618, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Drug
code
Controlled substance
Dated: December 13, 2023.
Shelly L. Cox,
Management Analyst, Rules Committee Staff.
PO 00000
DEPARTMENT OF JUSTICE
Marihuana ........................
Tetrahyrocannabinols ......
I
7360
7370
Schedule
I
II
The company plans to bulk
manufacture the listed controlled
substances as Active Pharmaceutical
Ingredients to its customers as well as
for research and clinical trials. In
reference to drug codes 7360
E:\FR\FM\18DEN1.SGM
18DEN1
87459
Federal Register / Vol. 88, No. 241 / Monday, December 18, 2023 / Notices
(Marihuana), and 7370
(Tetrahydrocannabinols) the company
plans to bulk manufacture these drug
codes as synthetic. No other activities
for these drug codes are authorized for
this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–27708 Filed 12–15–23; 8:45 am]
BILLING CODE P
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on November 28, 2023,
Siegfried USA, LLC, 33 Industrial Park
Road, Pennsville, New Jersey 08070,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
DEPARTMENT OF JUSTICE
Controlled substance
Drug Enforcement Administration
Phenylacetone .................
Opium, raw ......................
Poppy Straw Concentrate
[Docket No. DEA–1307]
Importer of Controlled Substances
Application: Siegfried USA, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Siegfried USA, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 17, 2024. Such
persons may also file a written request
for a hearing on the application on or
before January 17, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:41 Dec 15, 2023
Jkt 262001
I
Drug
code
Schedule
8501
9600
9670
II
II
II
I
The company plans to import the
listed controlled substances to
manufacture bulk Active
Pharmaceuticals Ingredients for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–27705 Filed 12–15–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1306]
Bulk Manufacturer of Controlled
Substances Application: AJNA
BioSciences
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Controlled substance
Psilocybin ........................
Psilocyn ...........................
I
Drug
code
Schedule
7437
7438
I
I
I
The company plans to bulk
manufacture by cultivating research
Good Manufacturing Practices whole
plant mushrooms containing Psilocybin
(7437) and Psilocyn (7438) to support
internal research, clinical trials, and
analytical purposes as well as to
distribute to their customers conducting
schedule I clinical research. No other
activities for these drug codes are
authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–27707 Filed 12–15–23; 8:45 am]
BILLING CODE P
AJNA BioSciences has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before February 16, 2024. Such
persons may also file a written request
SUMMARY:
for a hearing on the application on or
before February 16, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on September 20, 2023,
AJNA BioSciences, 8022 Southpark
Circle, Suite 500, Littleton, Colorado
80120–5659, applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1309]
Bulk Manufacturer of Controlled
Substances Application: Groff Health,
Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
E:\FR\FM\18DEN1.SGM
18DEN1
]]>Agencies
[Federal Register Volume 88, Number 241 (Monday, December 18, 2023)]
[Notices]
[Pages 87458-87459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27708]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1308]
Bulk Manufacturer of Controlled Substances Application:
Kinetochem LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Kinetochem LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
February 16, 2024. Such persons may also file a written request for a
hearing on the application on or before February 16, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 28, 2023, Kinetochem LLC, 96 Market Street,
Suite 102, Georgetown, Texas 78626-3618, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana............................... 7360 I
Tetrahyrocannabinols.................... 7370 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances as Active Pharmaceutical Ingredients to its customers as
well as for research and clinical trials. In reference to drug codes
7360
[[Page 87459]]
(Marihuana), and 7370 (Tetrahydrocannabinols) the company plans to bulk
manufacture these drug codes as synthetic. No other activities for
these drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-27708 Filed 12-15-23; 8:45 am]
BILLING CODE P
